SHE:300841 - Chengdu Kanghua Biological Products Co Ltd Chengdu Kanghua Biological Pro
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2015 Q4 2016 Q4 2017 Q4 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.14B
2.3%
1B
-12.4%
1.29B
29.0%
1.32B
2.3%
1.4B
5.9%
1.57B
11.9%
1.45B
-7.7%
1.46B
0.8%
1.42B
-2.5%
1.38B
-2.8%
1.58B
14.1%
1.61B
2.1%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 79.93M
14.9%
73.83M
-7.6%
83.75M
13.4%
83.45M
-0.4%
88.72M
6.3%
99.2M
11.8%
93.13M
-6.1%
95.58M
2.6%
94.11M
-1.5%
90.08M
-4.3%
102.15M
13.4%
97.12M
-4.9%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.06B
1.4%
928.42M
-12.8%
1.21B
30.2%
1.24B
2.5%
1.31B
5.9%
1.47B
11.9%
1.35B
-7.8%
1.36B
0.7%
1.33B
-2.6%
1.29B
-2.6%
1.48B
14.2%
1.51B
2.6%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 600.05M
-0.7%
527.14M
-12.2%
651.26M
23.5%
653.45M
0.3%
684.26M
4.7%
780.05M
14.0%
781.26M
0.2%
825.05M
5.6%
845.67M
2.5%
864.45M
2.2%
961.88M
11.3%
930.39M
-3.3%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 520.12M
-2.7%
453.3M
-12.8%
567.51M
25.2%
570M
0.4%
595.55M
4.5%
680.85M
14.3%
688.12M
1.1%
729.46M
6.0%
751.56M
3.0%
774.37M
3.0%
859.73M
11.0%
833.27M
-3.1%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 544.08M
5.7%
475.12M
-12.7%
641.19M
35.0%
668.58M
4.3%
715.97M
7.1%
787.15M
9.9%
665.47M
-15.5%
633.05M
-4.9%
575.73M
-9.1%
517.78M
-10.1%
615.51M
18.9%
680.26M
10.5%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 477.52M
-
- 829.48M
-
- 892.99M
-
- 598.07M
-
- 530.59M
-
- 509.22M
-
-
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 477.52M
7.6%
647.74M
35.6%
829.48M
28.1%
864.26M
4.2%
892.99M
3.3%
729.43M
-18.3%
598.07M
-18.0%
567.98M
-5.0%
530.59M
-6.6%
483.69M
-8.8%
509.22M
5.3%
553.49M
8.7%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 3.517
-1.2%
4.72
34.2%
6.146
30.2%
6.407
4.3%
6.626
3.4%
5.418
-18.2%
4.465
-17.6%
4.244
-5.0%
3.967
-6.5%
3.617
-8.8%
3.807
5.3%
4.141
8.8%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 3.517
-1.2%
4.72
34.2%
6.144
30.2%
6.406
4.2%
6.625
3.4%
5.417
-18.2%
4.464
-17.6%
4.243
-5.0%
3.965
-6.5%
3.615
-8.8%
3.807
5.3%
4.141
8.8%
Values are in CNY whenever applicable | Fiscal year ends on December 31
Powered by Morningstar

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms